Literature DB >> 15451796

Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.

Michael T Johnstone1, Alexandra S Perez, Imad Nasser, Robert Stewart, Anand Vaidya, Fawaz Al Ammary, Ben Schmidt, Gary Horowitz, Jennifer Dolgoff, James Hamilton, William C Quist.   

Abstract

BACKGROUND: Little is known about whether direct angiotensin receptor blockade can reduce atherosclerosis and plaque disruption. This study evaluated the effect of angiotensin receptor blockade on both the development of atherosclerosis and the disruption of plaque in a modified Constantinides animal model. METHODS AND
RESULTS: Twenty-eight New Zealand White rabbits underwent aortic balloon injury followed by a 1% cholesterol diet for 8 weeks. Thirteen rabbits received candesartan at 0.5 mg x kg(-1) x d(-1) beginning 2 days before aortic balloon injury and continued for the total 8 weeks of the cholesterol diet. The rabbits were then pharmacologically triggered and humanely killed, and their aortas were analyzed. The degree of atherosclerosis was determined by intima-media ratio of the infrarenal portion of the aorta. The frequency of intra-aortic thrombosis, a measure of plaque disruption, and the percentages of macrophage area and collagen-staining area of the plaque were determined. Candesartan-treated rabbits had less atherosclerosis (intima-media infrarenal aorta ratio of 1.18+/-0.08 versus 1.57+/-0.08 [mean+/-SEM] for the placebo group, P<0.001); fewer thrombi (3 of 13 versus 11 of 15; P<0.05); lower percentage area of macrophages to total plaque (18.8+/-2.7% versus 27+/-2.5%, P<0.05); and higher collagen to total plaque area (45+/-3% versus 35+/-2%, P<0.01).
CONCLUSIONS: These results demonstrate that angiotensin receptor blockade attenuates the degree of atherosclerosis and reduces both plaque disruption and macrophage accumulation while increasing collagen deposition in the aortas of this animal model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451796      PMCID: PMC2906248          DOI: 10.1161/01.CIR.0000143627.55926.4C

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Rabbit arterial thrombosis production by systemic procedures.

Authors:  P CONSTANTINIDES; R N CHAKRAVARTI
Journal:  Arch Pathol       Date:  1961-08

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.

Authors:  M Schwemmer; O Sommer; E Bassenge
Journal:  Cardiovasc Drugs Ther       Date:  2001-07       Impact factor: 3.727

Review 4.  The unstable atheroma.

Authors:  R T Lee; P Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

5.  Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.

Authors:  W B Strawn; M C Chappell; R H Dean; S Kivlighn; C M Ferrario
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

6.  Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis.

Authors:  A Prasad; K K Koh; W H Schenke; R Mincemoyer; G Csako; T A Fleischer; M Brown; T A Selvaggi; A A Quyyumi
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

7.  Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury.

Authors:  L Wu; M Iwai; H Nakagami; Z Li; R Chen; J Suzuki; M Akishita; M de Gasparo; M Horiuchi
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

8.  Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.

Authors:  G S Abela; P D Picon; S E Friedl; O C Gebara; A Miyamoto; M Federman; G H Tofler; J E Muller
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

9.  Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

Authors:  A J Naftilan; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

10.  Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

Authors:  D E Vaughan; S A Lazos; K Tong
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more
  10 in total

1.  Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.

Authors:  Hong Lu; Anju Balakrishnan; Deborah A Howatt; Congqing Wu; Richard Charnigo; Gene Liau; Lisa A Cassis; Alan Daugherty
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis.

Authors:  Maria Luigia Carbone; Gilliane Chadeuf; Sandrine Heurtebise-Chrétien; Xavier Prieur; Thibault Quillard; Yann Goueffic; Nathalie Vaillant; Marc Rio; Laure Castan; Maxim Durand; Céline Baron-Menguy; Julien Aureille; Juliette Desfrançois; Angela Tesse; Raul M Torres; Gervaise Loirand
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 14.808

3.  Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.

Authors:  Susumu Ishiguro; Kiyoshi Yoshimura; Ryouichi Tsunedomi; Masaaki Oka; Sonshin Takao; Makoto Inui; Atsushi Kawabata; Terrahn Wall; Vassiliki Magafa; Paul Cordopatis; Andreas G Tzakos; Masaaki Tamura
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells.

Authors:  Cheng Zhang; Yu Xia Zhao; Yue Hui Zhang; Li Zhu; Bi Ping Deng; Zhao Li Zhou; Shu Ying Li; Xiao Ting Lu; Li Li Song; Xue Ming Lei; Wen Bo Tang; Nan Wang; Chun Ming Pan; Huai Dong Song; Chun Xi Liu; Bo Dong; Yun Zhang; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

5.  A robust rabbit model of human atherosclerosis and atherothrombosis.

Authors:  Alkystis Phinikaridou; Kevin J Hallock; Ye Qiao; James A Hamilton
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

6.  Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques.

Authors:  Yiannis S Chatzizisis; Michael Jonas; Roy Beigel; Ahmet U Coskun; Aaron B Baker; Benjamin V Stone; Charles Maynard; Ross G Gerrity; William Daley; Elazer R Edelman; Charles L Feldman; Peter H Stone
Journal:  Atherosclerosis       Date:  2008-08-05       Impact factor: 5.162

7.  Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.

Authors:  Xiaofeng Chen; Hong Lu; Mingming Zhao; Katsuya Tashiro; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-11       Impact factor: 8.311

Review 8.  Prognostic Value and Therapeutic Perspectives of Coronary CT Angiography: A Literature Review.

Authors:  Patrizia Carità; Andrea Igoren Guaricci; Giuseppe Muscogiuri; Nazario Carrabba; Gianluca Pontone
Journal:  Biomed Res Int       Date:  2018-09-16       Impact factor: 3.411

9.  Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice.

Authors:  Jong-Ho Kim; I-Rang Lim; Hyung Joon Joo; Chi-Yeon Park; Seung-Cheol Choi; Han Saem Jeong; Soon Jun Hong
Journal:  Mol Med       Date:  2019-07-15       Impact factor: 6.354

10.  In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model.

Authors:  L Meng; B Lv; S Zhang; B Yv
Journal:  Heart       Date:  2007-10-18       Impact factor: 5.994

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.